Peptide Synthesis Market Size & Share, by Product (Equipment, Reagents & Consumables); Technology (Solid Phase, Liquid Phase, Hybrid & Recombinant); End-user {Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organization (CDMO), Research Institutes} - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4800
  • Published Date: Apr 08, 2023
  • Report Format: PDF, PPT

Companies Dominating the Peptide Synthesis Landscape

top-features-companies
    • CordenPharma International
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Evonik
    • CSBio Company Inc.
    • Bachem Holding AG
    • Biotage
    • AAPP Tec
    • CEM Corporation
    • ProteoGenix
    • GenScript
    • Thermo Fisher Scientific Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Evonik has released a new peptide to boost cell-culture-based biopharmaceutical productivity. cWrex AC provides cells with a sufficient supply of soluble sources of this amino acid. The peptide offers a reliable source of L-cystine, which is an essential component for cell-culture-based biopharmaceuticals. This makes it possible for biopharmaceutical companies to increase their productivity by providing cells with a consistent and sufficient supply of amino acids.
     
  • CordenPharma International Company announced a collaboration with PeptiSystems, a Swedish manufacturer of flow-through column-based instruments for the research and production of peptide and oligonucleotide therapeutics.

Author Credits:  Smruti Ranjan, Rajrani Baghel


  • Report ID: 4800
  • Published Date: Apr 08, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing expenditure by the pharmaceutical industry on R&D along with growth in drug approvals and high usage in COVID-19 treatment are some of the major factors anticipated to drive the growth of the polymer concrete market.

The market is anticipated to attain a CAGR of 10% over the forecast period, i.e., 2023-2035.

The major players in the market are Bachem Holding AG, Biotage, AAPP Tec, CEM Corporation, and others.

The pharmaceutical & biotechnology companies segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying